Search Within
Document Type
99-77-4
Applied Filters:
Keyword:'99-77-4'
Showing 1-30 of 373 results for "99-77-4" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79
The Effective Use of Protein Kinase Inhibitors
89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79
Testing Lab & Industrial Flyer
Nitrazine Yellow indicator grade, Dye content 85 % 5423-07-4 Analytical, Indicator
60700 Nuclear Fast Red for microscopy (Bot., Hist.) 6409-77-4 Analytical
16019 Phenolphthalein puriss., meets analytical
Dental Application Brochure
Hydroxyethyl methacrylate (HEMA) Monomer 868-77-9
Diurethane dimethacrylate (udma)
(bis (2-methacryloxyethyl) N, N’-1,
9-nonylene biscarbamate)
Monomer 72869-86-4
Triethylene glycol dimethacrylate
Data Sheet - MSST0058
mass (Da)
Length
(amino
acids)
Relative
Abundance
(%)
21-99 9108.6 79 12.6
23-99 8922.5 77 66.5
28-99 8385.7 72 20.9
Interleukin-8 (IL-8) is a member
Natural Lineage Markers
/ 52%
HPA001873 Anti-ACTN4 cytoskeleton ENSG00000130402 IHC,WB 99 / 98%
HPA006035 Anti-ACTN1 cytoskeleton ENSG00000072110 IHC,WB 98 / 99%
HPA008057 Anti-INA cytoskeleton ENSG00000148798 IHC 83 / 84%
Data Sheet - MSST0057
mass (Da)
Length
(amino
acids)
Relative
Abundance
(%)
21-99 9108.6 79 12.6
23-99 8922.5 77 66.5
28-99 8385.7 72 20.9
Interleukin-8 (IL-8) is a member
Verfication summary-03-0202-00
Recovery Range Serum: 77 – 105%
Plasma: 78 - 104%
CSF: 99 - 165%
Spike Recovery Mean Serum: 93%
Plasma: 94%
CSF: 123%
Verfication summary-03-0202-00
Recovery Range Serum: 77 – 105%
Plasma: 78 - 104%
CSF: 99 - 165%
Spike Recovery Mean Serum: 93%
Plasma: 94%
CSF: 123%
Data Sheet - A8909
density lipoprotein
(HDL). It consists of two identical subunits linked by a
disulfide bond.4 Apo A-II has 77 amino acid residues
with glutamine as C-terminal and pyrrolidonecarboxylic
acid (PCA) as N-terminal
Data Sheet - M9317
and Allis, C.D., Nature, 403, 41-45
(2000).
3. Bird, A., and Wolffe, A.P., Cell, 99, 451-454
(1999).
4. Razin, A., and Szyf, M., Biochim. Biophys. Acta.,
782, 331-342 (1984).
5.
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
DKFZp 250 4 269 3 274 5 347 4 156 4 102 3 253 4 352 7
IPI00784998 Hypothetical protein DKFZp 139 3 141 2 77 2 163 4 142 5 166 3 103 3 141 3 223 5
Data Sheet - M7443
A.P., Cell, 99,
451-454(1999).
4. Nur, I., et al., Nucleic Acids Res., 16,
9233-9251(1988).
5. Li, M., et al., Gene, 301, 43-51 (2002).
6. Razin, A., and Cedar, H., Cell, 77,
LABORATORY NOTEBOOK ISSUANCE PAGE
10
.8
1
12
.0
11
14
.0
07
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
LABORATORY NOTEBOOK ISSUANCE PAGE
10
.8
1
12
.0
11
14
.0
07
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
LABORATORY NOTEBOOK ISSUANCE PAGE
10
.8
1
12
.0
11
14
.0
07
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
Data Sheet - M6818
A.P., Cell, 99,
451-454 (1999).
4. Nur, I., et al., Nucleic Acids Res., 16,
9233-9251(1988).
5. Li, M., et al., Gene, 301, 43-51 (2002).
6. Razin, A., and Cedar, H., Cell, 77
Neutralization Efficacy of ICR Contact Plates App Note
ANIOSPRAY QUICK
Neutralization of Vesphene® III st Phenolic Disinfectant
130
82
66
105 105104 99 99
83
126
103
94 93 95
102
0
20
40
60
80
Data Sheet - D8559
U.S. Armed
Forces Med. J., 9:191
4. Schreir, 1969, Am. J. Clin. Pathol., 51:711.
5. Streitfeld, Hoffman and Janklow, 1962, J.Bact.
84:77.
D8559 11/99
Sigma brand products are sold through
Data Sheet - P3360
alpha-1-chymotrypsin-prostate-specific antigen in
prostate cancer diagnosis, Prostate, 47, 77-84
(2001).
4. Bjork, T., et al., Similar rates of exponential
decrease in serum concentrations of free
Bulletin - 710335P
chloroform solution
Purity > 99% Transition temp. No data
CAS 115404-77-8 CMC No data
Synonyms 18:1 CA PKA No data
Molec. Formula C81H148O17P2Na2 TLC mobile phase C:M:W & C:M:A*, 65:25:4,
v/v; C:Hexane:M:Acetic
Bulletin - 710335C
chloroform solution
Purity > 99% Transition temp. No data
CAS 115404-77-8 CMC No data
Synonyms 18:1 CA PKA No data
Molec. Formula C81H148O17P2Na2 TLC mobile phase C:M:W & C:M:A*, 65:25:4,
v/v; C:Hexane:M:Acetic
Data Sheet - S3442
inhibitors of glycogen synthase kinase-3 activity
protect primary neurones from death. J.
Neurochem., 77, 94-102 (2001).
3. Coghlan, M.P., et al., Selective small molecule
inhibitors of glycogen
Specification Sheet
7.25 psi) at 25°C
(77°F)
Operating
Temperature
Tube transfer system: Polyethylene: -20
to 50°C (-4 to 122°F); Silicone: -50 to
95°C (-58 to 203°F), C-Flex®: -73 to
132°C (-99 to 270°F)
Traceability
Quality Control Range Sheet- HST-111 and HST-211
pg/mL Control 2 52 – 108 pg/mL
IL-17A Control 1 25 – 52 pg/mL MIP-1β Control 1 37 – 77 pg/mL
Control 2
Product Information Sheet - E6888
effects of a statin, an
ACE-inhibitor and a low-molecular-weight heparin.
Thromb. Res., 108(1), 77-84 (2002).
8. Volpini, R. A., et al., Effect of enalapril and
losartan on the events that precede
DataSheet - P8340
α-Synuclein Neurodegeneration". University of
Pennsylvania, Ph.D. dissertation, pp. 42, 43, 48,
49, 77, 96, 97, 99 (2011).
9. Yu, Daozhan, "Omentin Activates AMP-activated
Protein Kinase and Plays a Role
Quality Control Ranges: Milliplex Human Cytokine / Chemokine Immunoassay
pg/mL Control 2 507 – 1053 pg/mL
IFN-γ Control 1 119 – 246 pg/mL sCD40L Control 1 77 – 160 pg/mL
Control 2
Product Information Sheet - O8801
Muchowski, J. Org. Chem., 42, 3709 (1977).
24 E. Kirii, M. Moriwaki, M. Abe, and Y. Ikeda, Japan. Kokai 77 73, 890 (1977); Chem. Abstr., 88, 6871y (1978).
25 M. Masaki and K. Fukui, Chem. Lett., 151 (1977
Product Information Sheet - A5394
3. Josephson, L. and Cantley, L.C., Jr., Biochem. 16, 4572 (1977).
4. Hudgins, P.M. and Bond G.H., Biochem. Biophys. Res. Comm., 77, 1024 (1977).
5. Beaugè, L.A. and Glynn I.M., Nature, 268, 355 (1977
Page 1 of 13